Jose Sanchez
Carmichael, CANPI 1356428916
Payments from drug & device makers
Across 88 payments — averaging $59.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$798
- Biohaven Pharmaceuticals, Inc.$613
- Amgen$561
- Genentech USA, Inc.$483
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$350
- Neurocrine Biosciences, Inc.$258
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,215100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $798 |
| Biohaven Pharmaceuticals, Inc. | 7 | $613 |
| Amgen | 28 | $561 |
| Genentech USA, Inc. | 4 | $483 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $350 |
| Neurocrine Biosciences, Inc. | 2 | $258 |
| AstraZeneca | 2 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $216 |
| MDD US Operations, LLC | 1 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $133 |
| Daiichi Sankyo Inc. | 1 | $132 |
| Orexo US, Inc. | 1 | $125 |
| Novo Nordisk | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Esperion Therapeutics, Inc. | 1 | $124 |
| Agios Pharmaceuticals, Inc. | 1 | $122 |
| Bristol Myers Squibb | 1 | $110 |
| Forte Bio-pharma LLC | 1 | $106 |
| Boehringer Ingelheim | 1 | $80 |
| Redhill Biopharma Inc. | 1 | $71 |
| Indivior Inc. | 4 | $70 |
| Collegium Pharmaceutical, Inc. | 1 | $58 |
| GRT US Holding, Inc. | 1 | $45 |
| Medtronic | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $1,736 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $1,317 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $1,229 |
| Methadone Hcl | 12 | $270 |
| Oxycodone Hcl | 11 | $206 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.